Literature DB >> 22079421

[Autoimmune channelopathies].

M Michaud1, J Delrieu, L Astudillo.   

Abstract

Autoimmune channelopathies are rare neuromuscular diseases that have been characterized clinically for several decades but for which the evidence of associated antibodies has only been recently demonstrated. Ion channels have an important role of activation, inhibition and regulation in neuromuscular transmission. Myasthenia gravis, generally associated with the presence of anti-acetylcholine receptor antibody, is the best-known channelopathy. Other anti-channel antibodies, including voltage-dependent, are associated with several neurological diseases, as illustrated by anti-voltage-gated calcium channels found in Lambert-Eaton myasthenic syndrome and paraneoplastic cerebellar ataxia, and anti-voltage-gated potassium channels found in neuromyotonia, Morvan's syndrome and limbic encephalitis. The treatment of autoimmune channelopathies is logically based on corticosteroids, immunosuppressant drugs, intravenous immunoglobulins and plasmapheresis.
Copyright © 2011 Société nationale française de médecine interne (SNFMI). Published by Elsevier SAS. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22079421     DOI: 10.1016/j.revmed.2011.04.003

Source DB:  PubMed          Journal:  Rev Med Interne        ISSN: 0248-8663            Impact factor:   0.728


  1 in total

1.  N-type calcium channel antibody-mediated autoimmune encephalitis: An unlikely cause of a common presentation.

Authors:  Leslie Finkel; Sookyong Koh
Journal:  Epilepsy Behav Case Rep       Date:  2013-06-28
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.